Lobbying

American Society for Biochemistry and Molecular Biology's latest lobbying report covers Q2 2026, at $8,980. The four quarters Q4 2025–Q3 2026 total $29K. Its first report covers Q4 2022; the issues it reports most are Budget/Appropriations and Science/Technology.

American Society for Biochemistry and Molecular Biology

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$29K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

American Society for Biochemistry and Molecular Biology lobbying by quarter
American Society for Biochemistry and Molecular Biology lobbying by quarter
QuarterAmountReports
Q4 2022$01
Q1 2023$01
Q2 2023$01
Q3 2023$01
Q4 2023$01
Q1 2024$01
Q2 2024$01
Q3 2024$01
Q4 2024$10K1
Q1 2025$10K1
Q2 2025$10K1
Q3 2025$5,0001
Q4 2025$10K1
Q1 2026$10K1
Q2 2026$8,9801
Q3 2026$00

By issue

  • Budget and appropriations$37K · 15 reports
  • Science and technology$27K · 13 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES15 reports
  • SENATE15 reports

Firms it paid

Firm
In-houseAmerican Society for Biochemistry and Molecular Biology$64K15 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
07/14for Q2In-house$8,980
05/15for Q4 2025In-house$10K
03/19for Q1In-house$10K
01/09for Q4 2025In-house$10K
25/10/20for Q3 2025In-house$5,000
25/07/17for Q2 2025In-house$10K
25/05/01for Q4 2024In-house$10K
25/05/01for Q3 2024In-houseUnder $5,000
25/05/01for Q2 2024In-houseUnder $5,000
25/05/01for Q1 2024In-houseUnder $5,000
25/04/21for Q1 2025In-house$10K
25/01/13for Q4 2024In-houseUnder $5,000
24/10/08for Q3 2024In-houseUnder $5,000
24/08/27for Q2 2024In-houseUnder $5,000
24/05/02for Q1 2024In-houseUnder $5,000
24/01/08for Q4 2023In-houseUnder $5,000
23/11/29for Q3 2023In-houseUnder $5,000
23/07/10for Q2 2023In-houseUnder $5,000
23/04/03for Q1 2023In-houseUnder $5,000
23/01/17for Q4 2022In-houseUnder $5,000